MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2005.09.005

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2005

Leukocyte suppression is associated with improved clinical outcomes in children's status after orthotopic heart transplantation.

Kim Jeffrey J, Dreyer William J, O'Brian Smith E, Price Jack F, Clunie Sarah, Dimas V Vasiliki, Jefferies John L, Rosenblatt Howard, Radovancevic Branislav, Towbin Jeffrey A, Denfield Susan W

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Leukocyte suppression is a sequela of immunosuppressive therapy after orthotopic heart transplantation and may result in discontinuation of anti-proliferative agents. Clinical outcomes in this patient population have not been well delineated.

METHODS

This study was a retrospective review of children who underwent orthotopic heart transplantation at our institution from 1986 to 2003. Leukocyte suppression was defined as a white blood cell count <5,000, prompting the withdrawal of anti-proliferative agents. The population was divided into 2 groups, leukosuppressed (LS) and non-leukosuppressed (NLS), and their clinical outcomes were compared.

RESULTS

The study included 109 patients, of which 44 (40%) became leukosuppressed. The 2 groups were similar regarding demographic data and initial management. The LS Group had a significantly decreased incidence of rejection, being 7 times less likely to have recurrent rejection (p = 0.001). The median time to rejection was 0.8 +/- 0.6 years for the NLS Group, whereas the median time to rejection was not yet reached at 17 years for the LS Group. The LS Group also tended toward a decreased incidence of retransplantation or death (p = 0.06). The organ "half-life" in the NLS Group was 7.5 years vs 12.5 years in the LS Group. There was no difference between the 2 groups in regards to other adverse effects of immunosuppression.

CONCLUSIONS

Children who have undergone orthotopic heart transplantation and subsequently become leukosuppressed have a lower incidence of rejection and a tendency toward less organ loss than children who do not become leukosuppressed, without having an increased incidence of adverse side effects.

Для цитирования: Kim Jeffrey J, Dreyer William J, O'Brian Smith E, Price Jack F, Clunie Sarah, Dimas V Vasiliki, Jefferies John L, Rosenblatt Howard, Radovancevic Branislav, Towbin Jeffrey A, Denfield Susan W. Leukocyte suppression is associated with improved clinical outcomes in children's status after orthotopic heart transplantation.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2005. DOI: 10.1016/j.healun.2005.09.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.